{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T16:54:19Z","timestamp":1792083259718,"version":"4.4.0"},"reference-count":51,"publisher":"American Association for Cancer Research (AACR)","issue":"7","funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA217648"],"award-info":[{"award-number":["R01CA217648"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA123088"],"award-info":[{"award-number":["R01CA123088"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA099985"],"award-info":[{"award-number":["R01CA099985"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA193136"],"award-info":[{"award-number":["R01CA193136"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA152470"],"award-info":[{"award-number":["R01CA152470"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"name":"University of Michigan Rogel Cancer Center Grant","award":["CA46592"],"award-info":[{"award-number":["CA46592"]}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>Mutations in IFN and MHC signaling genes endow immunotherapy resistance. Patients with colorectal cancer infrequently exhibit IFN and MHC signaling gene mutations and are generally resistant to immunotherapy. In exploring the integrity of IFN and MHC signaling in colorectal cancer, we found that optineurin was a shared node between the two pathways and predicted colorectal cancer patient outcome. Loss of optineurin occurs in early-stage human colorectal cancer. Immunologically, optineurin deficiency was shown to attenuate IFNGR1 and MHC-I expression, impair T-cell immunity, and diminish immunotherapy efficacy in murine cancer models and patients with cancer. Mechanistically, we observed that IFNGR1 was S-palmitoylated on Cys122, and AP3D1 bound with and sorted palmitoylated IFNGR1 to lysosome for degradation. Unexpectedly, optineurin interacted with AP3D1 to prevent palmitoylated IFNGR1 lysosomal sorting and degradation, thereby maintaining IFN\u03b3 and MHC-I signaling integrity. Furthermore, pharmacologically targeting IFNGR1 palmitoylation stabilized IFNGR1, augmented tumor immunity, and sensitized checkpoint therapy. Thus, loss of optineurin drives immune evasion and intrinsic immunotherapy resistance in colorectal cancer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>Loss of optineurin impairs the integrity of both IFN\u03b3 and MHC-I signaling pathways via palmitoylation-dependent IFNGR1 lysosomal sorting and degradation, thereby driving immune evasion and intrinsic immunotherapy resistance in colorectal cancer. Our work suggests that pharmacologically targeting IFNGR1 palmitoylation can stabilize IFNGR1, enhance T-cell immunity, and sensitize checkpoint therapy in colorectal cancer.<\/jats:p>\n                    <jats:p>See related commentary by Salvagno and Cubillos-Ruiz, p. 1623.<\/jats:p>\n                    <jats:p>This article is highlighted in the In This Issue feature, p. 1601<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/2159-8290.cd-20-1571","type":"journal-article","created":{"date-parts":[[2021,2,24]],"date-time":"2021-02-24T12:40:18Z","timestamp":1614170418000},"page":"1826-1843","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":131,"title":["Loss of Optineurin Drives Cancer Immune Evasion via Palmitoylation-Dependent IFNGR1 Lysosomal Sorting and Degradation"],"prefix":"10.1158","volume":"11","author":[{"given":"Wan","family":"Du","sequence":"first","affiliation":[{"name":"1Department of Surgery, University of Michigan School of Medicine, Ann Arbor, Michigan."},{"name":"2Center of Excellence for Cancer Immunology and Immunotherapy, University of Michigan School of Medicine, Ann Arbor, Michigan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6214-1384","authenticated-orcid":false,"given":"Fang","family":"Hua","sequence":"additional","affiliation":[{"name":"1Department of Surgery, University of Michigan School of Medicine, Ann Arbor, Michigan."},{"name":"2Center of Excellence for Cancer Immunology and Immunotherapy, University of Michigan School of Medicine, Ann Arbor, Michigan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiong","family":"Li","sequence":"additional","affiliation":[{"name":"1Department of Surgery, University of Michigan School of Medicine, Ann Arbor, Michigan."},{"name":"2Center of Excellence for Cancer Immunology and Immunotherapy, University of Michigan School of Medicine, Ann Arbor, Michigan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhang","sequence":"additional","affiliation":[{"name":"1Department of Surgery, University of Michigan School of Medicine, Ann Arbor, Michigan."},{"name":"2Center of Excellence for Cancer Immunology and Immunotherapy, University of Michigan School of Medicine, Ann Arbor, Michigan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shasha","family":"Li","sequence":"additional","affiliation":[{"name":"1Department of Surgery, University of Michigan School of Medicine, Ann Arbor, Michigan."},{"name":"2Center of Excellence for Cancer Immunology and Immunotherapy, University of Michigan School of Medicine, Ann Arbor, Michigan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weichao","family":"Wang","sequence":"additional","affiliation":[{"name":"1Department of Surgery, University of Michigan School of Medicine, Ann Arbor, Michigan."},{"name":"2Center of Excellence for Cancer Immunology and Immunotherapy, University of Michigan School of Medicine, Ann Arbor, Michigan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajia","family":"Zhou","sequence":"additional","affiliation":[{"name":"1Department of Surgery, University of Michigan School of Medicine, Ann Arbor, Michigan."},{"name":"2Center of Excellence for Cancer Immunology and Immunotherapy, University of Michigan School of Medicine, Ann Arbor, Michigan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weimin","family":"Wang","sequence":"additional","affiliation":[{"name":"1Department of Surgery, University of Michigan School of Medicine, Ann Arbor, Michigan."},{"name":"2Center of Excellence for Cancer Immunology and Immunotherapy, University of Michigan School of Medicine, Ann Arbor, Michigan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8409-5574","authenticated-orcid":false,"given":"Peng","family":"Liao","sequence":"additional","affiliation":[{"name":"1Department of Surgery, University of Michigan School of Medicine, Ann Arbor, Michigan."},{"name":"2Center of Excellence for Cancer Immunology and Immunotherapy, University of Michigan School of Medicine, Ann Arbor, Michigan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijian","family":"Yan","sequence":"additional","affiliation":[{"name":"1Department of Surgery, University of Michigan School of Medicine, Ann Arbor, Michigan."},{"name":"2Center of Excellence for Cancer Immunology and Immunotherapy, University of Michigan School of Medicine, Ann Arbor, Michigan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaopeng","family":"Li","sequence":"additional","affiliation":[{"name":"1Department of Surgery, University of Michigan School of Medicine, Ann Arbor, Michigan."},{"name":"2Center of Excellence for Cancer Immunology and Immunotherapy, University of Michigan School of Medicine, Ann Arbor, Michigan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Wei","sequence":"additional","affiliation":[{"name":"1Department of Surgery, University of Michigan School of Medicine, Ann Arbor, Michigan."},{"name":"2Center of Excellence for Cancer Immunology and Immunotherapy, University of Michigan School of Medicine, Ann Arbor, Michigan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Grove","sequence":"additional","affiliation":[{"name":"1Department of Surgery, University of Michigan School of Medicine, Ann Arbor, Michigan."},{"name":"2Center of Excellence for Cancer Immunology and Immunotherapy, University of Michigan School of Medicine, Ann Arbor, Michigan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Vatan","sequence":"additional","affiliation":[{"name":"1Department of Surgery, University of Michigan School of Medicine, Ann Arbor, Michigan."},{"name":"2Center of Excellence for Cancer Immunology and Immunotherapy, University of Michigan School of Medicine, Ann Arbor, Michigan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3838-5789","authenticated-orcid":false,"given":"Witold","family":"Zgodzi\u0144ski","sequence":"additional","affiliation":[{"name":"3The 2nd Department of General Surgery, Medical University of Lublin, Lublin, Poland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"Majewski","sequence":"additional","affiliation":[{"name":"3The 2nd Department of General Surgery, Medical University of Lublin, Lublin, Poland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grzegorz","family":"Wallner","sequence":"additional","affiliation":[{"name":"3The 2nd Department of General Surgery, Medical University of Lublin, Lublin, Poland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoyan","family":"Chen","sequence":"additional","affiliation":[{"name":"4State Key Laboratory for Oncogenes and Related Genes, Key Laboratory of Gastroenterology and Hepatology, Ministry of Health, Division of Gastroenterology and Hepatology, Shanghai Institute of Digestive Disease, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3130-2533","authenticated-orcid":false,"given":"Ilona","family":"Kryczek","sequence":"additional","affiliation":[{"name":"1Department of Surgery, University of Michigan School of Medicine, Ann Arbor, Michigan."},{"name":"2Center of Excellence for Cancer Immunology and Immunotherapy, University of Michigan School of Medicine, Ann Arbor, Michigan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Yuan","family":"Fang","sequence":"additional","affiliation":[{"name":"3The 2nd Department of General Surgery, Medical University of Lublin, Lublin, Poland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiping","family":"Zou","sequence":"additional","affiliation":[{"name":"1Department of Surgery, University of Michigan School of Medicine, Ann Arbor, Michigan."},{"name":"2Center of Excellence for Cancer Immunology and Immunotherapy, University of Michigan School of Medicine, Ann Arbor, Michigan."},{"name":"5Department of Pathology, University of Michigan School of Medicine, Ann Arbor, Michigan."},{"name":"6Graduate Program in Immunology, University of Michigan School of Medicine, Ann Arbor, Michigan."},{"name":"7Graduate Program in Tumor Biology, University of Michigan School of Medicine, Ann Arbor, Michigan."},{"name":"8University of Michigan Rogel Cancer Center, University of Michigan School of Medicine, Ann Arbor, Michigan."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2021,2,24]]},"reference":[{"key":"2022060711072440600_bib1","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.ccell.2015.03.001","article-title":"Immune checkpoint blockade: a common denominator approach to cancer therapy","volume":"27","author":"Topalian","year":"2015","journal-title":"Cancer Cell"},{"key":"2022060711072440600_bib2","doi-asserted-by":"crossref","first-page":"328rv4","DOI":"10.1126\/scitranslmed.aad7118","article-title":"PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: mechanisms, response biomarkers, and combinations","volume":"8","author":"Zou","year":"2016","journal-title":"Sci Transl Med"},{"key":"2022060711072440600_bib3","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1056\/NEJM200001133420201","article-title":"Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer","volume":"342","author":"Gryfe","year":"2000","journal-title":"N Engl J Med"},{"key":"2022060711072440600_bib4","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/sj.bjc.6604867","article-title":"Deficient mismatch repair system in patients with sporadic advanced colorectal cancer","volume":"100","author":"Koopman","year":"2009","journal-title":"Br J Cancer"},{"key":"2022060711072440600_bib5","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1053\/j.gastro.2009.12.064","article-title":"Microsatellite instability in colorectal cancer","volume":"138","author":"Boland","year":"2010","journal-title":"Gastroenterology"},{"key":"2022060711072440600_bib6","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1056\/NEJMoa1500596","article-title":"PD-1 blockade in tumors with mismatch-repair deficiency","volume":"372","author":"Le","year":"2015","journal-title":"N Engl J Med"},{"key":"2022060711072440600_bib7","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1126\/science.aan6733","article-title":"Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade","volume":"357","author":"Le","year":"2017","journal-title":"Science"},{"key":"2022060711072440600_bib8","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nrc1586","article-title":"Immunosuppressive networks in the tumour environment and their therapeutic relevance","volume":"5","author":"Zou","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"2022060711072440600_bib9","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1056\/NEJMoa1604958","article-title":"Mutations associated with acquired resistance to PD-1 blockade in melanoma","volume":"375","author":"Zaretsky","year":"2016","journal-title":"N Engl J Med"},{"key":"2022060711072440600_bib10","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1038\/s41467-017-01062-w","article-title":"Resistance to checkpoint blockade therapy through inactivation of antigen presentation","volume":"8","author":"Sade-Feldman","year":"2017","journal-title":"Nat Commun"},{"key":"2022060711072440600_bib11","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1158\/2159-8290.CD-16-1223","article-title":"Primary resistance to PD-1 blockade mediated by JAK1\/2 mutations","volume":"7","author":"Shin","year":"2017","journal-title":"Cancer Discov"},{"key":"2022060711072440600_bib12","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.cell.2016.08.069","article-title":"Loss of IFN-\u03b3 pathway genes in tumor cells as a mechanism of resistance to anti-CTLA-4 therapy","volume":"167","author":"Gao","year":"2016","journal-title":"Cell"},{"key":"2022060711072440600_bib13","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nature14404","article-title":"Melanoma-intrinsic \u03b2-catenin signalling prevents anti-tumour immunity","volume":"523","author":"Spranger","year":"2015","journal-title":"Nature"},{"key":"2022060711072440600_bib14","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nature15520","article-title":"Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy","volume":"527","author":"Peng","year":"2015","journal-title":"Nature"},{"key":"2022060711072440600_bib15","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.cell.2018.05.052","article-title":"LSD1 ablation stimulates anti-tumor immunity and enables checkpoint blockade","volume":"174","author":"Sheng","year":"2018","journal-title":"Cell"},{"key":"2022060711072440600_bib16","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nature23270","article-title":"In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target","volume":"547","author":"Manguso","year":"2017","journal-title":"Nature"},{"key":"2022060711072440600_bib17","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nature23477","article-title":"Identification of essential genes for cancer immunotherapy","volume":"548","author":"Patel","year":"2017","journal-title":"Nature"},{"key":"2022060711072440600_bib18","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41586-018-0768-9","article-title":"Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockade","volume":"565","author":"Ishizuka","year":"2019","journal-title":"Nature"},{"key":"2022060711072440600_bib19","first-page":"PO.18.00321","article-title":"Majority of B2M-mutant and -deficient colorectal carcinomas achieve clinical benefit from immune checkpoint inhibitor therapy and are microsatellite instability-high","volume":"3","author":"Middha","year":"2019","journal-title":"JCO Precis Oncol"},{"key":"2022060711072440600_bib20","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s41586-020-2746-2","article-title":"Functional genomic landscape of cancer-intrinsic evasion of killing by T cells","volume":"586","author":"Lawson","year":"2020","journal-title":"Nature"},{"key":"2022060711072440600_bib21","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.cell.2019.03.030","article-title":"Proteogenomic analysis of human colon cancer reveals new therapeutic opportunities","volume":"177","author":"Vasaikar","year":"2019","journal-title":"Cell"},{"key":"2022060711072440600_bib22","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/nature13438","article-title":"Proteogenomic characterization of human colon and rectal cancer","volume":"513","author":"Zhang","year":"2014","journal-title":"Nature"},{"key":"2022060711072440600_bib23","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/s41588-020-0636-z","article-title":"Lineage-dependent gene expression programs influence the immune landscape of colorectal cancer","volume":"52","author":"Lee","year":"2020","journal-title":"Nat Genet"},{"key":"2022060711072440600_bib24","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.cell.2019.08.012","article-title":"Proteomics of melanoma response to immunotherapy reveals mitochondrial dependence","volume":"179","author":"Harel","year":"2019","journal-title":"Cell"},{"key":"2022060711072440600_bib25","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1172\/JCI96113","article-title":"Host expression of PD-L1 determines efficacy of PD-L1 pathway blockade-mediated tumor regression","volume":"128","author":"Lin","year":"2018","journal-title":"J Clin Invest"},{"key":"2022060711072440600_bib26","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1172\/JCI96061","article-title":"PD-L1 on host cells is essential for PD-L1 blockade-mediated tumor regression","volume":"128","author":"Tang","year":"2018","journal-title":"J Clin Invest"},{"key":"2022060711072440600_bib27","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1126\/science.272.5264.1008","article-title":"Enhanced degradation of EGF receptors by a sorting nexin, SNX1","volume":"272","author":"Kurten","year":"1996","journal-title":"Science"},{"key":"2022060711072440600_bib28","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41586-018-0756-0","article-title":"FBXO38 mediates PD-1 ubiquitination and regulates anti-tumour immunity of T cells","volume":"564","author":"Meng","year":"2018","journal-title":"Nature"},{"key":"2022060711072440600_bib29","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/B978-0-12-394305-7.00005-7","article-title":"Cellular and molecular biology of optineurin","volume":"294","author":"Ying","year":"2012","journal-title":"Int Rev Cell Mol Biol"},{"key":"2022060711072440600_bib30","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1083\/jcb.137.4.835","article-title":"Characterization of the adaptor-related protein complex, AP-3","volume":"137","author":"Simpson","year":"1997","journal-title":"J Cell Biol"},{"key":"2022060711072440600_bib31","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1111\/tra.12277","article-title":"Lysosomal targeting of cystinosin requires AP-3","volume":"16","author":"Andrzejewska","year":"2015","journal-title":"Traffic"},{"key":"2022060711072440600_bib32","doi-asserted-by":"crossref","first-page":"14612","DOI":"10.1038\/ncomms14612","article-title":"Misrouting of v-ATPase subunit V0a1 dysregulates lysosomal acidification in a neurodegenerative lysosomal storage disease model","volume":"8","author":"Bagh","year":"2017","journal-title":"Nat Commun"},{"key":"2022060711072440600_bib33","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1083\/jcb.200610151","article-title":"Palmitoylation-dependent protein sorting","volume":"176","author":"Greaves","year":"2007","journal-title":"J Cell Biol"},{"key":"2022060711072440600_bib34","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1042\/BST20160236","article-title":"Protein S-palmitoylation in cellular differentiation","volume":"45","author":"Zhang","year":"2017","journal-title":"Biochem Soc Trans"},{"key":"2022060711072440600_bib35","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/nrn2788","article-title":"Protein palmitoylation in neuronal development and synaptic plasticity","volume":"11","author":"Fukata","year":"2010","journal-title":"Nat Rev Neurosci"},{"key":"2022060711072440600_bib36","doi-asserted-by":"crossref","first-page":"8709","DOI":"10.1074\/jbc.R110.210005","article-title":"Ion channel regulation by protein palmitoylation","volume":"286","author":"Shipston","year":"2011","journal-title":"J Biol Chem"},{"key":"2022060711072440600_bib37","doi-asserted-by":"crossref","first-page":"15900","DOI":"10.1074\/jbc.M113.469866","article-title":"Palmitoylation of protease-activated receptor-1 regulates adaptor protein complex-2 and -3 interaction with tyrosine-based motifs and endocytic sorting","volume":"288","author":"Canto","year":"2013","journal-title":"J Biol Chem"},{"key":"2022060711072440600_bib38","doi-asserted-by":"crossref","first-page":"e0179529","DOI":"10.1371\/journal.pone.0179529","article-title":"MDD-Palm: identification of protein S-palmitoylation sites with substrate motifs based on maximal dependence decomposition","volume":"12","author":"Weng","year":"2017","journal-title":"PLoS One"},{"key":"2022060711072440600_bib39","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/nrm2084","article-title":"Palmitoylation: policing protein stability and traffic","volume":"8","author":"Linder","year":"2007","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2022060711072440600_bib40","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1126\/science.aau6391","article-title":"Palmitoylation of NOD1 and NOD2 is required for bacterial sensing","volume":"366","author":"Lu","year":"2019","journal-title":"Science"},{"key":"2022060711072440600_bib41","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/s41589-019-0344-0","article-title":"Toll-like receptor mediated inflammation requires FASN-dependent MYD88 palmitoylation","volume":"15","author":"Kim","year":"2019","journal-title":"Nat Chem Biol"},{"key":"2022060711072440600_bib42","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nri819","article-title":"Cytotoxic T lymphocytes: all roads lead to death","volume":"2","author":"Barry","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"2022060711072440600_bib43","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-019-1170-y","article-title":"CD8(+) T cells regulate tumour ferroptosis during cancer immunotherapy","volume":"569","author":"Wang","year":"2019","journal-title":"Nature"},{"key":"2022060711072440600_bib44","doi-asserted-by":"crossref","first-page":"7556","DOI":"10.1073\/pnas.95.13.7556","article-title":"Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice","volume":"95","author":"Kaplan","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022060711072440600_bib45","doi-asserted-by":"crossref","first-page":"5999","DOI":"10.1073\/pnas.1602069113","article-title":"NLRC5\/MHC class I transactivator is a target for immune evasion in cancer","volume":"113","author":"Yoshihama","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022060711072440600_bib46","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ccell.2017.01.004","article-title":"Inactivation of interferon receptor promotes the establishment of immune privileged tumor microenvironment","volume":"31","author":"Katlinski","year":"2017","journal-title":"Cancer Cell"},{"key":"2022060711072440600_bib47","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41577-019-0218-4","article-title":"Tumour-intrinsic resistance to immune checkpoint blockade","volume":"20","author":"Kalbasi","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"2022060711072440600_bib48","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1038\/ncb2589","article-title":"Autophagy receptors link myosin VI to autophagosomes to mediate Tom1-dependent autophagosome maturation and fusion with the lysosome","volume":"14","author":"Tumbarello","year":"2012","journal-title":"Nat Cell Biol"},{"key":"2022060711072440600_bib49","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1146\/annurev.immunol.15.1.563","article-title":"The IFN gamma receptor: a paradigm for cytokine receptor signaling","volume":"15","author":"Bach","year":"1997","journal-title":"Annu Rev Immunol"},{"key":"2022060711072440600_bib50","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.immuni.2014.03.010","article-title":"IL-22(+)CD4(+) T cells promote colorectal cancer stemness via STAT3 transcription factor activation and induction of the methyltransferase DOT1L","volume":"40","author":"Kryczek","year":"2014","journal-title":"Immunity"},{"key":"2022060711072440600_bib51","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1470-2045(11)70318-7","article-title":"EGFR expression as a predictor of survival for first-line chemotherapy plus cetuximab in patients with advanced non-small-cell lung cancer: analysis of data from the phase 3 FLEX study","volume":"13","author":"Pirker","year":"2012","journal-title":"Lancet Oncol"}],"container-title":["Cancer Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerdiscovery\/article-pdf\/11\/7\/1826\/3105854\/1826.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerdiscovery\/article-pdf\/11\/7\/1826\/3105854\/1826.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,7]],"date-time":"2022-06-07T07:14:00Z","timestamp":1654586040000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerdiscovery\/article\/11\/7\/1826\/666548\/Loss-of-Optineurin-Drives-Cancer-Immune-Evasion"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,24]]},"references-count":51,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2021,2,24]]},"published-print":{"date-parts":[[2021,7,1]]}},"URL":"https:\/\/doi.org\/10.1158\/2159-8290.cd-20-1571","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/2159-8290.22540280.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.22540280","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/2159-8290.c.6549344","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2159-8290.c.6549344.v1","asserted-by":"object"}]},"ISSN":["2159-8274","2159-8290"],"issn-type":[{"value":"2159-8274","type":"print"},{"value":"2159-8290","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,24]]}}}